Nn9932-4954
Research payments
$2,716,458
Through program year 2024, $2,716,458 in research payments was reported against Nn9932-4954, across 664 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $731,234 | 188 |
| 2023 | Research | $1,549,605 | 301 |
| 2022 | Research | $435,618 | 175 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ildiko Lingvay Dallas, TX Named on 124 payments
- Philip O'Donnell Winchester, VA Named on 102 payments
- William Garvey Birmingham, AL Named on 95 payments
- Domenica Rubino Arlington, VA Named on 81 payments
- Kevin Cannon Wilmington, NC Named on 77 payments
- Isaac Beshay Costa Mesa, CA Named on 73 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.